Exam 3: Hepatitis Flashcards
Hepatitis common symptoms/signs
n/v/d abdominal pain fever jaundice elevated AST/ALT
Hep A and E family, envelope status, transmission
RNA pico (A), RNA hepe (E) - similar to calici Naked, acid stable Fecal oral A: shellfish, travelers, day care E: waterborne
Hep A vaccine, passive immunization, dx on serum
Killed vaccine
Passive vaccination with preformed abs
Dx = HAV IgM
Hep A on liver biopsy
Hepatocyte swelling
monocyte infection
Councilman bodies (extracyto, eosinophilic)
Hep E highlight reel
Reservoir
3 E’s of Hep E
Fulminant hepatitis in 3rd trimester pregnant women
No FDA approved vaccine
Res: pigs
Expectant, Enteric, Epidemic
Hep B family, envelop status, transmission
DNA hepadnavirus
Enveloped
Blood/Baby (sex)/Birth
Hep B acuity and vaccine
Acute infection, minority (10%) go chronic
Vaccine: one serotype, Anti-HBs only in vaccinated
Hep B vertical transmission
Cycled between mother/daughter/mother/daughter
Active and passive immunization of newborn to stop cycle
Hep B replication
Genome size
Unique features
Small genome, very efficient Overlapping ORFs (making gene one way makes something else the other way) Partial single partial double DNA Reverse transcriptase (on egression rather than entry)
Age differences in Hep B infection
Young: don’t get sick, don’t clear -> chronic
Old: get sick, clear -> less chronic
Treatment/serum monitoring:
Acute infection
Neonate
Immune response with fall of HBsAg and rise of Anti-HBs is acute and will probably clear
High HBsAg with no Anti-HBs -> going chronic
No acute treatment - self limited
Neonate: active and passive immunity with positive mom
Treatment for chronic HBV
Tenofovir (RT inhibitor)
Treatment depends on viral load
HDV infection, genome, replication
Requires HBV coinfection
Circular ssRNA (-) with delta antigen (infectious part)
Replication via host Pol2 (rolling circle)
HCV treatment history
93: IFN, ribavirin
00: peg-IFN, ribavirin
11: peg-IFN, ribavirin, protease inhibitors (STEP1)
15: direct acting anti-virals
HCV genome
Structural genes: C, E1, E2
Replication/non-structural: NS3, NS5a etc - target for drug